Tianjin Ringpu Bio-Technology Co.,Ltd. (SHE:300119)

Market Cap	8.46B +5.7%
Revenue (ttm)	3.40B +10.7%
Net Income	400.51M +33.2%
EPS	0.88 +34.9%
Shares Out	454.07M
PE Ratio	21.15
Forward PE	18.46
Dividend	0.30 (1.59%)
Ex-Dividend Date	May 21, 2025

Volume	4,668,380
Average Volume	6,200,164
Open	17.60
Previous Close	18.64
Day's Range	17.60 - 18.78
52-Week Range	16.44 - 28.90
Beta	0.37
RSI	47.69
Earnings Date	Mar 31, 2026

About SHE:300119

Tianjin Ringpu Bio-Technology Co.,Ltd. engages in the research and development, production, and sale of veterinary raw materials, pharmaceutical preparation, functional additives, and veterinary biological products. The company provides vaccines, chemical drugs, traditional Chinese medicines; feed additives, including pigs, chickens, waterfowl, cattle, sheep and pet medicines, and vaccines; and poultry, waterfowl, livestock, rumination, pets, washing and disinfection, active pharmaceutical ingredients product series. It also offers diagnosis an...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1998
• Employees: 2,900
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300119

Financial Performance

In 2025, SHE:300119's revenue was 3.40 billion, an increase of 10.70% compared to the previous year's 3.07 billion. Earnings were 400.51 million, an increase of 33.18%.